Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

The Cochrane Database of Systematic Reviews
Agnieszka SliwkaMalgorzata M Bala

Abstract

Three classes of inhaler medication are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta₂-agonists (LABA); long-acting muscarinic antagonists (LAMA); and inhaled corticosteroids (ICS). To encourage patient adherence, two classes of medication are often combined in a single medication device; it seems that once-daily dosing offers greatest convenience to patients and may markedly influence adherence. To compare a once-daily combination of inhaled corticosteroid and long-acting beta₂-agonist inhalers (ICS/LABA) versus inhaled long-acting muscarinic antagonists alone (LAMA) for people with chronic obstructive pulmonary disease (COPD). We performed an electronic search of the Specialised Register of the Cochrane Airways Group (14 May 2018), ClinicalTrials.gov (14 May 2018), and the World Health Organization International Clinical Trials Registry Platform (20 September 2017), then a search of other resources, including reference lists of included studies and manufacturers' trial registers (10 October 2017). Two pairs of review authors screened and scrutinised selected articles. We included randomised controlled trials (RCTs) comparing once-daily administered ICS/LABA and LAMA in adults with COPD. Two rev...Continue Reading

References

Dec 10, 1988·BMJ : British Medical Journal·H ChrystynM D Peake
Aug 1, 1995·American Journal of Respiratory and Critical Care Medicine·C S RandJ Connett
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·C S Kim, T C Kang
Dec 19, 2003·The European Respiratory Journal·P M CalverleyH Olsson
Apr 23, 2005·The Cochrane Database of Systematic Reviews·R G BarrF S F Ram
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Jul 17, 2007·Respiratory Medicine·Raid A M Al-ShowairHenry Chrystyn
Oct 6, 2007·American Journal of Respiratory and Critical Care Medicine·Jadwiga A WedzichaUNKNOWN INSPIRE Investigators
Jun 27, 2008·The European Respiratory Journal·D M ManninoF Holguin
Aug 8, 2008·Respiratory Medicine·Stefano GuerraFernando D Martinez
Aug 30, 2008·Thorax·J Bourbeau, S J Bartlett
Apr 4, 2009·American Journal of Respiratory and Critical Care Medicine·Robab KohansalJoan B Soriano
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Sep 8, 2010·Current Medical Research and Opinion·Meaghan St CharlesDouglas Mapel
Sep 14, 2010·Respiratory Research·Alvar AgustiUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
Sep 17, 2010·The New England Journal of Medicine·John R HurstUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Mar 4, 2011·Respiratory Medicine·Stephanie KornUNKNOWN INSIST study group
Mar 25, 2011·The New England Journal of Medicine·Claus VogelmeierUNKNOWN POET-COPD Investigators
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Sally SpencerDavid J Evans
Jun 4, 2013·The Cochrane Database of Systematic Reviews·Emma J WelshPhillippa Poole
Aug 2, 2013·The European Respiratory Journal·François MaltaisThomas J Ferro
Mar 29, 2014·The Cochrane Database of Systematic Reviews·Kayleigh M KewChristopher J Cates
Aug 4, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Nobuyuki HoritaTakeshi Kaneko
Nov 26, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Afisi Segun IsmailaAndreas Karabis
Jan 6, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Henry CovelliCourtney Crim

❮ Previous
Next ❯

Citations

Sep 8, 2018·The European Respiratory Journal·Alvar AgustiAlberto Papi
Apr 14, 2018·The European Respiratory Journal·Signe Vedel-KroghSune F Nielsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.